155 related articles for article (PubMed ID: 1930876)
1. A comparison between the non-competitive NMDA antagonist dizocilpine (MK-801) and the competitive NMDA antagonist D-CPPene with regard to dopamine turnover and locomotor-stimulatory properties in mice.
Svensson A; Pileblad E; Carlsson M
J Neural Transm Gen Sect; 1991; 85(2):117-29. PubMed ID: 1930876
[TBL] [Abstract][Full Text] [Related]
2. Differential locomotor interactions between dopamine D1/D2 receptor agonists and the NMDA antagonist dizocilpine in monoamine-depleted mice.
Svensson A; Carlsson A; Carlsson ML
J Neural Transm Gen Sect; 1992; 90(3):199-217. PubMed ID: 1363051
[TBL] [Abstract][Full Text] [Related]
3. Concurrent locomotor stimulation and decrease in dopamine release in rats and mice after treatment with the competitive NMDA receptor antagonists D-CPPene and CGS 19755.
Waters N; Lundgren C; Hansson LO; Carlsson ML
J Neural Transm (Vienna); 1996; 103(1-2):117-29. PubMed ID: 9026366
[TBL] [Abstract][Full Text] [Related]
4. The non-competitive NMDA antagonists MK-801 and PCP, as well as the competitive NMDA antagonist SDZ EAA494 (D-CPPene), interact synergistically with clonidine to promote locomotion in monoamine-depleted mice.
Carlsson M; Svensson A
Life Sci; 1990; 47(19):1729-36. PubMed ID: 2147454
[TBL] [Abstract][Full Text] [Related]
5. Effect of the NMDA receptor antagonist, MK-801, on locomotor activity and on the metabolism of dopamine in various brain areas of mice.
Liljequist S; Ossowska K; Grabowska-Andén M; Andén NE
Eur J Pharmacol; 1991 Mar; 195(1):55-61. PubMed ID: 1829683
[TBL] [Abstract][Full Text] [Related]
6. The 5-HT2A receptor antagonist M100907 is more effective in counteracting NMDA antagonist- than dopamine agonist-induced hyperactivity in mice.
Carlsson ML; Martin P; Nilsson M; Sorensen SM; Carlsson A; Waters S; Waters N
J Neural Transm (Vienna); 1999; 106(2):123-9. PubMed ID: 10226932
[TBL] [Abstract][Full Text] [Related]
7. Behavioural and neurochemical adaptations to nicotine in rats: influence of NMDA antagonists.
Shoaib M; Benwell ME; Akbar MT; Stolerman IP; Balfour DJ
Br J Pharmacol; 1994 Apr; 111(4):1073-80. PubMed ID: 8032593
[TBL] [Abstract][Full Text] [Related]
8. Effects of D1 and D2 dopamine receptor antagonists and catecholamine depleting agents on the locomotor stimulation induced by dizocilpine in mice.
Lapin IP; Rogawski MA
Behav Brain Res; 1995 Oct; 70(2):145-51. PubMed ID: 8561905
[TBL] [Abstract][Full Text] [Related]
9. Differential behavioural and neurochemical effects of competitive and non-competitive NMDA receptor antagonists in rats.
Bubser M; Keseberg U; Notz PK; Schmidt WJ
Eur J Pharmacol; 1992 Dec; 229(1):75-82. PubMed ID: 1361915
[TBL] [Abstract][Full Text] [Related]
10. The impact of a competitive and a non-competitive NMDA receptor antagonist on dopaminergic neurotransmission in the rat ventral tegmental area and substantia nigra.
Wedzony K; Czyrak A; Maćkowiak M; Fijał K
Naunyn Schmiedebergs Arch Pharmacol; 1996 Apr; 353(5):517-27. PubMed ID: 8740145
[TBL] [Abstract][Full Text] [Related]
11. The glycine/NMDA receptor antagonist, R-(+)-HA-966, blocks activation of the mesolimbic dopaminergic system induced by phencyclidine and dizocilpine (MK-801) in rodents.
Bristow LJ; Hutson PH; Thorn L; Tricklebank MD
Br J Pharmacol; 1993 Apr; 108(4):1156-63. PubMed ID: 8485625
[TBL] [Abstract][Full Text] [Related]
12. Involvement of N-methyl-D-aspartate (NMDA) receptors in noncompetitive NMDA receptor antagonist-induced hyperlocomotion in mice.
Irifune M; Shimizu T; Nomoto M; Fukuda T
Pharmacol Biochem Behav; 1995; 51(2-3):291-6. PubMed ID: 7667342
[TBL] [Abstract][Full Text] [Related]
13. Competitive and noncompetitive N-methyl-D-aspartate antagonists protect dopaminergic and serotonergic neurotoxicity produced by methamphetamine in various brain regions.
Ohmori T; Koyama T; Muraki A; Yamashita I
J Neural Transm Gen Sect; 1993; 92(2-3):97-106. PubMed ID: 7690233
[TBL] [Abstract][Full Text] [Related]
14. Lowered brain stimulation reward thresholds in rats treated with a combination of caffeine and N-methyl-D-aspartate but not alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate or metabotropic glutamate receptor-5 receptor antagonists.
Bespalov A; Dravolina O; Belozertseva I; Adamcio B; Zvartau E
Behav Pharmacol; 2006 Jun; 17(4):295-302. PubMed ID: 16914947
[TBL] [Abstract][Full Text] [Related]
15. Rodent data and general hypothesis: antipsychotic action exerted through 5-Ht2A receptor antagonism is dependent on increased serotonergic tone.
Martin P; Waters N; Schmidt CJ; Carlsson A; Carlsson ML
J Neural Transm (Vienna); 1998; 105(4-5):365-96. PubMed ID: 9720968
[TBL] [Abstract][Full Text] [Related]
16. The central aromatic amino acid DOPA decarboxylase inhibitor, NSD-1015, does not inhibit L-DOPA-induced circling in unilateral 6-OHDA-lesioned-rats.
Treseder SA; Rose S; Jenner P
Eur J Neurosci; 2001 Jan; 13(1):162-70. PubMed ID: 11135014
[TBL] [Abstract][Full Text] [Related]
17. Electrical but not chemical kindling increases sensitivity to some phencyclidine-like behavioral effects induced by the competitive NMDA receptor antagonist D-CPPene in rats.
Wlaź P; Ebert U; Potschka H; Löscher W
Eur J Pharmacol; 1998 Jul; 353(2-3):177-89. PubMed ID: 9726648
[TBL] [Abstract][Full Text] [Related]
18. Modulation of the mesolimbic dopamine system by glutamate: role of NMDA receptors.
Kretschmer BD
J Neurochem; 1999 Aug; 73(2):839-48. PubMed ID: 10428083
[TBL] [Abstract][Full Text] [Related]
19. Synergistic interactions between the NMDA antagonist dizocilpine and the preferential dopamine autoreceptor antagonists (+)-AJ 76 and (+)-UH 232 with regard to locomotor stimulation in monoamine-depleted mice.
Svensson A; Carlsson M; Carlsson A
J Neural Transm Gen Sect; 1991; 85(1):69-77. PubMed ID: 1867840
[TBL] [Abstract][Full Text] [Related]
20. In vivo protection of striatum from MPP+ neurotoxicity by N-methyl-D-aspartate antagonists.
Santiago M; Venero JL; Machado A; Cano J
Brain Res; 1992 Jul; 586(2):203-7. PubMed ID: 1521154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
